Dose-dependent neuroprotection of delta opioid peptide [d-Ala2, d-Leu5] enkephalin in neuronal death and retarded behavior induced by forebrain ischemia in rats

Neuroscience Letters

Volumn 423, Issue 2, 2007, Pages 113-117

  Su, Dian san ^a   Wang, Zhen hong ^a   Zheng, Yong jun ^a   Zhao, Yan hua ^a   Wang, Xiang rui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

DADLE; Forebrain ischemia; Intracerebroventricular administration; Morris water maze; Neuroprotection; Rats

Indexed keywords

ENKEPHALIN[2 DEXTRO ALANINE 5 DEXTRO LEUCINE]; NALTRINDOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; BEHAVIOR CHANGE; BRAIN ISCHEMIA; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; ELECTROENCEPHALOGRAM; HIPPOCAMPUS; MALE; MAZE TEST; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN ISCHEMIA; CELL DEATH; DOSE-RESPONSE RELATIONSHIP, DRUG; ENKEPHALIN, LEUCINE-2-ALANINE; INJECTIONS, INTRAVENTRICULAR; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; NEURONS; NEUROPROTECTIVE AGENTS; PROSENCEPHALON; RATS; RATS, SPRAGUE-DAWLEY;

EID: 34547871256     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.044     Document Type: Article

References (22)

1. Baker A.K., and Meert T.F. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice. J. Pharmacol. Exp. Ther. 302 (2002) 1253-1264
2. Barry U., and Zuo Z. Opioids: old drugs for potential new applications. Curr. Pharm. Des. 11 (2005) 1343-1350
3. Borlongan C.V., Su T.P., and Wang Y. Treatment of delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 11 (2000) 923-926
4. Borlongan C.V., Su T.-P., and Wang Y. Treatment with delta opioid peptide enhances in vitro and in vivo survival of rat dopaminergic neurons. Neuroreport 11 (2000) 923-926
5. Chao D., Donnelly D.F., Feng Y., Bazzy-Asaad A., and Xia Y. Cortical delta-opioid receptors potentiate K(+) homeostasis during anoxia and oxygen-glucose deprivation. J. Cereb. Blood Flow Metab. 27 (2007) 356-368
6. Chen W., Yang J.Z., Andersen R., Nielsen L.H., and Borchardt R.T. Evaluation of the permeation characteristics of a model opioid peptide, H-Tyr-d-Ala-Gly-Phe-d-Leu-OH (DADLE), and its cyclic prodrugs across the blood brain barrier using an in situ perfused rat brain model. J. Pharmacol. Exp. Ther. 303 (2002) 849-857
7. Gallagher M., Burwell R., and Burchinal M. Severity of spatial learning impairment in aging: development of a learning index for performance in the Morris water maze. Behav. Neurosci. 107 (1993) 618-626
8. Gionet T.X., Thomas J.D., Warner D.S., Goodlett C.R., Wasserman E.A., and West J.R. Forebrain ischemia induces selective behavioral impairments associated with hippocampal injury in rats. Stroke 22 (1991) 1040-1047
9. Hayashi T., Hirata H., Asanuma M., Ladenheim B., Tsao L.-I., Cadet J.L., and Su T.-P. Delta opioid peptide [d-Ala2, d-Leu5] enkephalin causes a near complete blockade of the neuronal damage induced by a single high dose of methamphetamine: examining the role of p53. Synapse 39 (2001) 305-312
10. Hayashi T., Tsao L.I., and Su T.P. Antiapoptotic and cytotoxic properties of delta opioid peptide [d-Ala2, d-Leu5] enkephalin in PC12 cells. Synapse 43 (2002) 86-94
11. Iwata M., Inoue S., Kawaguchi M., Kurita N., Horiuchi T., Nakamura M., Konishi N., and Furuya H. Delta opioid receptors stimulation with [d-Ala(2), d-Leu(5)] enkephalin does not provide neuroprotection in the hippocampus in rats subjected to forebrain ischemia. Neurosci. Lett. 414 (2007) 242-246
12. Liu Z., Fan Y., Won S.J., Neumann M., Hu D., Zhou L., Weinstein P.R., and Liu J. Chronic treatment with minocycline preserves adult new neurons and reduces functional impairment after focal cerebral ischemia. Stroke 38 (2007) 146-152
13. Ma D., Hossain M., Chow A., Arshad M., Battson R.M., Sanders R.D., Mehmet H., Edwards A.D., Franks N.P., and Maze M. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann. Neurol. 58 (2005) 182-193
14. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11 (1984) 47-60
15. Oeltgen P.R., Horton N.D., Bolling S.F., and Su T.-P. Extended lung preservation with the use of hibernation trigger factors. Ann. Thorac. Surg. 61 (1996) 1488-1493
16. Philipose L.E., Alphs H., Prabhakaran V., and Hillis A.E. Testing conclusions from functional imaging of working memory with data from acute stroke. Behav. Neurol. 18 (2007) 37-43
17. Schultz J.E., and Gross G.J. Opioids and cardioprotection. Pharmacol. Ther. 89 (2001) 123-137
18. Schultz J.E., Hsu A.K., and Gross G.J. Ischemic preconditioning in the intact rat heart is mediated by delta1- not mu- or kappa-opioid receptors. Circulation 97 (1998) 1282-1289
19. Tsao L.I., Ladenheim B., Andrews A.M., Chiueh C.C., Cadet J.L., and Su T.P. Delta opioid peptide [d-Ala2, d-Leu5] enkephalin blocks the long-term loss of dopamine transporter induced by multiple administration of methamphetamine: involvement of opioid receptors and reactive oxygen species. J. Pharmacol. Exp. Ther. 287 (1998) 322-331
20. Zhang J.H., Haddad G.G., and Xia Y. Delta, but not mu and kappa, opioid receptor activation protects neocortical neurons from glutamate-induced excitotoxic injury. Brain Res. 885 (2000) 143-153
21. Zhang J., Geoffrey T.G., Zhao P., and Xia Y. Neuroprotective role of delta opioid receptors in cortical neurons. Am. J. Physiol. Cell Physiol. 282 (2002) C1225-C1234
22. Zhao P., Guo J.C., Xia Y., Hong S.S., Bazzy-Asaad A., Cheng J.S., and Xia Y. Electro-acupuncture and brain protection from cerebral ischemia: The role of delta-opioid receptor. Soc. Neurosci. abstr. (2002)